Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Amneal
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminop...

Amneal
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC has been granted approval for the ANDA040746 filing, securing the generic market for FDA-approved, oral-conditioned hydroco...

DR
FDA Approves Unknown Drug — DR REDDYS LABS INC

On August 23, 2006, Dr. Reddy's Laboratories received FDA approval for ANDA077787, marking a key move to expand its generic drug portfolio. The approv...

GRAVITI
FDA Approves Unknown Drug — GRAVITI PHARMS

Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate rev...

Organon
FDA Approves NEXPLANON — Organon LLC

Organon LLC reported the U.S. Food and Drug Administration's approval of its subcutaneous implantable contraceptive, NEXPLANON, marking a pivotal expa...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

Sandoz announced late Tuesday that its ANDA submission for the New Drug Application, ANDA075428, received FDA approval on January 24. This clearance i...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA INTL

Strides Pharma Intl announced the approval of a generic drug application in January 2006. This early-stage development marked a significant step for t...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA INTL

Strides Pharma International announced today that the U.S. Food and Drug Administration approved its Abbreviated New Drug Application (ANDA) for the s...

SOLA
FDA Approves CABERGOLINE — SOLA Pharmaceuticals, LLC

# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabe...

SUN
FDA Approves Unknown Drug — SUN PHARM INDUSTRIES

SUN PHARM INDUSTRIES received final FDA approval on December 21 for ANDA077124, signaling a potential generic opportunity in the previously undetermin...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC

SUN PHARM INDUSTRIES announced the release of Abbreviated New Drug Application (ANDA #077184) on December 16; however, details regarding the specific ...

Torrent
FDA Approves CARBAMAZEPINE — Torrent Pharmaceuticals Limited

# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine...

Teva
FDA Approves GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. received FDA approval for ANDA088477 regarding the brand-name GLIPIZIDE AND METFORMIN HYDROCHLORIDE, expanding competit...

EPIC
FDA Approves Unknown Drug — EPIC PHARMA LLC

Epic Pharma LLC announced the approval of its Abbreviated New Drug Application (ANDA) for generic drug **[Substance]** on October 27, 2005. This clear...

BARR
FDA Approves Unknown Drug — BARR

# FDA Approves Generic Drug Application for Barr Pharmaceuticals Barr Pharmaceuticals received FDA approval for ANDA077083 on September 13, 2005, exp...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

PHARMOBEDIENT announced the approval of NDA #____ (ANDA076650), scheduled generic launch on September 13, 2005. Bankers expect the approval to generat...

Takeda
FDA Approves ACTOPLUS MET — Takeda Pharmaceuticals America, Inc.

Following Takeda Pharmaceuticals’ expansion into the thyroid disease market, the company was granted FDA approval on August 29, 2005, for Actoplus Met...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS ELIZABETH

Actavis Elizabeth has been granted FDA approval for a new generic drug, marking the company's continued entry into the generic pharmaceutical market. ...

Oceanside
FDA Approves METFORMIN HYDROCHLORIDE — Oceanside Pharmaceuticals

Oceanside Pharmaceuticals announced the FDA approval of oral Metformin Hydrochloride (NDA021748), a market expansion that offers a potential cost-effe...

Viona
FDA Approves METFORMIN HYDROCHLORIDE — Viona Pharmaceuticals Inc

Viona Pharmaceuticals Inc. has secured an approval for its DMF waiver on the generic label for metformin hydrochloride, opening the door to significan...